Unlike FDA-approved products, consumers and prescribers cannot assume that compounded drugs were made by validated processes in properly calibrated and cleaned equipment; that the ingredients in the drug were obtained from FDA-approved sources; that

find more production personnel had the requisite knowledge and training; and that appropriate laboratory testing was performed to verify the compounded drug’s potency, purity, and quality. In the case of sterile compounding, there are also Smoothened antagonist concerns about the adequacy of environmental monitoring, which includes microbiological testing of the facility, equipment, air purification, and water. The shelf-life of compounded products is typically not verified by stability testing; therefore, compounded preparations cannot be assumed to retain their original strength and purity over time. Pharmacies making copies of commercially available products for economically driven reasons, rather than genuine medical need, are also engaged in improper compounding, as this circumvents important public health requirements [10]. A significant concern is the use of active and inactive ingredients that are from foreign sources www.selleckchem.com/products/MS-275.html and not manufactured

under GMPs to create the unapproved copies. The FDA has stated that consumers would be better served by commercially available drugs, which have been determined to be safe and effective and manufactured under rigorous GMP requirements [1]. In 2001, a Kansas City-based pharmacist was discovered to have adulterated 72 different drugs, including many oncology medications, Nintedanib (BIBF 1120) to increase profits. According to law enforcement estimates, the pharmacist diluted approximately 98,000 prescriptions for 4,200 patients over an 11-year time period [11]. This drug adulteration was detected not by clinicians or patients,

but rather by a pharmaceutical sales representative who noted that the pharmacy was selling considerably more drugs than it was buying. Illegal activities of this nature are by no means typical of pharmacy compounding, but this case illustrates that clinical observation alone cannot be relied upon to detect quality problems in medicines. 3.3 Compounded Sterile Preparations (CSPs) The primary standard for the compounding of sterile medications is USP chapter 〈797〉 Pharmaceutical Compounding: Sterile Preparations, which specifies the conditions and practices that should be used to prevent harm to patients from microbial contamination, bacterial endotoxins, chemical and physical contaminants, and ingredients of inappropriate quality. USP 〈797〉 classifies aseptic manipulation of sterile products or ingredients as low-risk sterile compounding. However, the sterility assurance level (SAL) of preparations compounded by an aseptic process is, at best, several orders of magnitude lower than the SAL of terminally sterilized pharmaceutical products manufactured under GMPs.

Angew Chem Int Ed 2005, 44:2737–2742.CrossRef 33. Peng K, Lu A, Zhang R, Lee S-T: Motility of metal nanoparticles in silicon and induced anisotropic silicon etching. Adv Funct Mater 2008, 18:3026–3035.CrossRef 34. Morinaga H, Suyama M, Ohmi T: Mechanism of metallic particle growth and metal‒induced pitting on selleckchem Si wafer surface in wet chemical processing. J Electrochem Soc 1994, 141:2834–2841.CrossRef 35. Hildreth OJ, Lin W, Wong CP:

Effect of catalyst shape and etchant composition on etching direction in metal-assisted chemical etching of silicon to fabricate 3D nanostructures. ACS Nano 2009, 3:4033–4042.CrossRef 36. Hildreth OJ, Fedorov AG, Wong CP: 3D spirals with controlled chirality fabricated using metal-assisted

chemical etching of silicon. ACS Nano 2012, 6:10004–10012.CrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions JH conceived the idea and planned the experiments. JH and JD performed, analyzed, and CH5183284 in vivo optimized the step-and-repeat nanoimprint lithography process. JH performed the gold-assisted chemical etching LY2835219 clinical trial and SEM. JH and QW carried out the TEM and analyzed the data. AT and SC participated in the design and coordination of the study. All the authors contributed to the preparation and revision of the manuscript, as well as, read and approved it.”
“Background TiO2 nanoparticles (NPs) have been widely investigated in the recent past due to their applications in a wide range of fields including solar cells [1], water photolysis for hydrogen production [2], sensors [3], and antireflective and photochromic devices

[4]. TiO2 has three well-known crystallographic phases in nature: anatase, rutile, and brookite. Among these, anatase has been proved to have excellent chemical and physical properties for environmental remediation [5] and many other uses [6–8]. Numerous methods for the synthesis of TiO2 NPs have been developed, such as hydrolytic sol-gel process [9], nonhydrolytic sol-gel process [10], hydrothermal methods [11], solvothermal methods [12], Nintedanib (BIBF 1120) and so on. The synthesis of TiO2 nanoparticles generally involves hydrolysis and condensation of titanium precursors. The titanium precursors are extremely water sensitive; therefore, in conventional aqueous/alcohol-phase/sol-gel method in conventional solution-phase synthetic routes, small amount of water is used to inhibit the hydrolysis. However, prepared TiO2 NPs suffer from poor crystallinity and inferior material properties as compared to those prepared through high-temperature, nonhydrolytic methods.

040) and 234% (P = 0.022), respectively (Figure 7F). This result provides further experimental evidence that PRDM1α is directly silenced by miR-223. However, we found no distinct changes in PRDM1α expression in NK92 cells (Figure 7F, P = 1.000), even though the level of endogenous miR-223 diminished to 55.90% (Figure 7E, P = 0.026). Other miRNAs or signals in NK92 cells may G418 regulate PRDM1 expression. Representative images of PRDM1α protein expression in NK92, NKL, and K562 cells are

shown in Figure 7G. Association of miR-223 with clinical factors of EN-NK/T-NT patients We attempted to analyse the potential biological role of miR-223 expression in 21 EN-NK/T-NT cases. miR-223 positive staining Omipalisib manufacturer showed no significant correlation with sex, age, tumour stage, or patient status and had no significant effects on the 5-year OS rate, OS, or FFS (Table 2, Figure 8A and B). The lack of a significant association between miR-223 expression and clinical factors in EN-NK/T-NT patients may be due to the limited sample size; future studies should include more patients. Figure 8 Kaplan-Meier survival selleck compound analysis of miR-223 in extranodal NK/T-cell lymphoma, nasal type (EN-NK/T-NT) patients. According

to Kaplan-Meier survival analysis, no correlation was investigated between the expression status of miR-223 and on overall survival (OS) (A , P = 0.784) and failure-free survival (FFS) (B, P = 0.691) of EN-NK/T-NT patients. Discussion

It is becoming clear that PRDM1 functions as a tumour suppressor gene in lymphomas. The inactivation or downregulation of PRDM1 appears to be a common event in activated B cell-like diffuse large B cell lymphoma and is associated with various events including missense mutations, biallelic gene deletions, or the post-transcriptional inhibition of let-7 [19, 22, 23]. Although research on PRDM1 in NK/T-cell lymphoma is rapidly increasing [18], few studies have examined PRDM1 in Asian EN-NK/T-NT patients, which constitute a large portion of the incidence of this disease in the world. The present investigation demonstrated that immunostaining of PRDM1 might be prognostic in EN-NK/T-NT. We observed only weak PRDM1 positivity in about one quarter of the EN-NK/T-NT cases (24.59%), consistent with the findings of Iqbal and Karube Interleukin-3 receptor et al., who reported low levels of PRDM1 expression in NK-cell neoplasms and cell lines compared to normal NK cells [11, 13]. However, Ng et al. reported PRDM1 overexpression in 50% (17/34) of NK/T-cell lymphomas [7]. Therefore, studies describing the detection of PRDM1 by IHC are still limited and inconsistent. Because PRDM1 expression could be an important predictor of EN-NK/T-NT, standardisation of immunohistochemical procedures (such as antibodies and the conditions for antigen retrieval and staining evaluation) is necessary to reduce the inconsistency of PRDM1 protein measurements.

He presented with a fever, had decreased breath sounds on the right side, and his vital signs were stable (pulse was 100, blood pressure was 140/90 mmHg. Physical examination revealed a single skin laceration (2.0 cm) with surrounding contusion at the right mid-axillary line; 4th intercostal space. The admission chest radiograph revealed a small right pneumothorax, pulmonary contusion and radiopaque material within the right middle lobe (Figure 1). A right-sided thoracostomy tube drained

minimal air and blood. A computed tomography (CT) scan of the chest demonstrated a foreign body in the right hemithorax with the form of an AM-403/P attenuated energy projectile (Figure 2). Due to septic complications and the size of the foreign body, the patient underwent a right thoracotomy which revealed CA-4948 cost a 19 g (6.5 × 2.5 cm) AZD1390 supplier projectile within

the middle lobe, which was surrounded by an intra-parenchymal hematoma (Figure 3). The projectile and injured parenchyma were removed by wedge resection. The patient had an uneventful hospital stay and was discharged home 5 days later. Figure 1 Admission chest radiography. Admission chest radiograph shows a radiopaque image within a pulmonary contusion (arrow), and a small pneumothorax on the right hemithorax. Figure 2 Admission CT scan of the chest. CT three-dimensional (3D) image reconstruction of the chest shows an intra-thoracic attenuated energy projectile and a chest thoracostomy tube inside the right hemithorax. Figure 3 Intra-operative

finding. Intra-operative photograph depicts the AM-403/P attenuated energy projectile within the lung parenchyma during wedge resection. Discussion “”Less-lethal”" weapons Protein kinase N1 are explicitly designed and primarily employed to incapacitate personnel, while minimizing fatalities [4]. There are many classes of “”less lethal weapons”" including conducted electrical weapons (commonly referred to as a TASER), chemical irritants (Pepper spray), and impact munitions. Impact munitions include “”bean bag rounds”", rubber bullets, plastic baton rounds, and attenuated energy projectile. As our case is an example of a serious injury caused by a rubber bullet, we focused our literature review on chest injuries caused by rubber and plastic “”less lethal”" munitions from 1972 to 2008 (Table 1). Table 1 Articles published in the English language pertaining to thoracic injuries caused by rubber and plastic “”less-lethal”" impact munitions (1972–2009) selleck chemical Author/Year Bullet Type/Speed/ Energy Range (m) Total Cases/Chest Intra-thoracic Penetration Significant thoracic injuries Outcome Shaw J. 1972 Rubber 150 g/ 116.5 m/s/* 27.4 3^ No Lung contusion (3) All survived Millar R. 1975 Rubber 140 g/73 m/s/* * 90/18 No Lung contusion(5), pneumothorax(1), rib fracture(2) All survived Sheridan S. 1983 Plastic 135 g/*/* * 147/21 * * * Rocke L. 1983 Plastic/*/* * 99/10 No Lung contusion(7), rib fracture(1) All survived Ritchie A. 1990;1992 Plastic 134.5 g/69.

Poor flocculation and settling of the DMXAA mw activated sludge lead to poor effluent quality and can cause environmental problems in the receiving waters. The sludge characteristics depend on the microbial community composition [2–4], the microbial activity [5] and the properties of the extra-cellular polymeric substances in the flocs [6, 7]. The bacterial community has been characterized in click here a number of activated sludge systems [8, 9] but very little is known about archaeal communities in sludge. The presence of Archaea in activated sludge has been shown by fluorescence in situ hybridization (FISH), e.g. [10]. Methanogens [11, 12] and putative ammonia-oxidizing

Archaea (AOA) [13–15] have been detected by amplification of 16S rRNA and archaeal ammonia monooxygenase subunit A genes. Although present, Archaea seem to be of minor importance

for Enzalutamide nmr both nitrogen and carbon removal [11, 16]. However, it is still possible that the Archaea have other functions or affect the properties of the activated sludge. Addition of methanogens to the sludge in intermittently aerated bioreactors increased the rates of specific oxygen uptake, denitrification and nitrification suggesting a symbiotic relationship with Bacteria [17]. The composition of the methanogenic community in anaerobic sludge has been shown to be crucial for the structure and integrity of granules [18–20] and if methanogens are present in activated sludge they may contribute to the floc structure. This study had three aims. The first was to describe the Archaea community in the

activated sludge of a full-scale WWTP by cloning and sequencing of 16S rRNA genes. Although there are many studies where activated sludge samples have been screened for the presence of AOA (e.g. [13–15]), to our knowledge there are only two published studies on the diversity of Archaea in activated sludge from a full-scale WWTP [11, 12]. One of the studies PD184352 (CI-1040) investigated two small WWTPs [11] and the other a seawater-processing WWTP [12]. The Rya WWTP is a large WWTP treating municipal and industrial wastewater, thus different from the WWTPs in those two studies. Since little is known about Archaea in WWTPs and, importantly, sequence coverage for Archaea from WWTPs is still modest, the 16S rRNA sequences we obtained here would indicate if published FISH probes were relevant. If so, the second aim was to quantify the Archaea by confocal microscopy and FISH and to determine their localization in the flocs. The third aim was to follow the dynamics of the Archaea community for a longer period of time using terminal restriction fragment length polymorphism (T-RFLP) analysis. For the third aim, the samples that were used were collected for previous studies of the dynamics of the floc composition and flocculation and settling properties of the activated sludge at the Rya WWTP [21, 22].

Biotic interaction between protists and viruses are also known and have been shown [64]. Viruses specifically infect protists, e.g. the Coccolithovirus and it’s host, the calicifying haptophyte Emiliania huxleyi[65]. Additionally, viruses can also have

an an indirect influence on protists by infecting the bacteria on which the protistan grazers feed or protistan grazers can even feed directly on viruses even though the carbon transfer to the higher trophic level is of minor importance [66]. Furthermore, different bacterioplankton communities can produce a bottom-up control on grazing selleck products protists. Namely, the growth efficiency of protists can relate strongly to the available bacterial prey [63, 67]. This is highly likely because differences in bacterial community composition in DHABs have been shown before [68, 69]. That leads to the assumption that different bacterial communities support different phagotrophic protists that show strong preferences for particular prey species [63, 67, 70, 71] or morphotypes [72, 73]. Other possible

explanations are founder effects, which BYL719 purchase describe a genetic deviation of an isolated MM-102 in vitro population or founder population (on an island for example) compared to the original population based on a low number of alleles within the founders individuals [74], random effects or genetic drift is the change in the frequency of a gene in a population due to random sampling [75] and random extinctions that describe when a gene causes its carriers to have a deviating fitness from unity, its frequency will be determined by selection [76] in different basins. For protists in particular there is no literature available on this topic to our knowledge. At last, the Monoplization Hypothesis by De Meester et al. [77] could be relevant to protist biogeography Thiamet G stating that a fast population growth and local adaptation

and colonization of a new habitat result in the monopolization of resources, which yields a strong priority effect. The effect is even enhanced when a locally adapted population can provide a ‘large resting propagule bank’ as a strong buffer against new genotypes invading. This holds true especially for species that reproduce asexually and form resting stages. Even though mass effect and dispersal [78] cannot be ruled out, these are unlikely alternatives to explain the observed community patterns. The habitats of the water column above the DHABs represent a potential source habitat with ‘high quality’. In comparison, the narrow interphase and the brine show ‘low quality’ conditions because these habitats harbor high gradients of change, anoxia, high salt concentration up to saturation and therefore require a high degree of physiological adaptation for microbial colonization. Chances for highly specialized organisms to cross environmental barriers outside their habitat and to disperse beyond their specific habitat are very low.

CrossRef 31. Smith LT, Smith GM, Madkour MA: Osmoregulation in Agrobacterium tumefaciens : accumulation of a novel disaccharide is controlled by osmotic strength and glycine betaine. J Bacteriol 1990, 172:6849–6855.PubMed 32. Avonce N, Mendoza-Vargas A, Morett E, Iturriaga G: Insights on the evolution of S3I-201 in vivo Trehalose biosynthesis. BMC Evol KPT-8602 Biol 2006, 6:109.PubMedCrossRef 33. Styrvold OB, Kaasen I, Strøm AR: Biochemical and genetic characterization of osmoregulatory trehalose synthesis in Escherichia coli . J Bacteriol 1998, 170:2841–2849. 34. Franco-Rodríguez G, González-Jiménez I, Tejero-Mateo P, Molina-Molina J, Doblado JA,

Megías M, Romero MJ: The structure and molecular mechanisms calculations of the cyclic (1→2)-β-D-glucan secreted by Rhizobium tropici CIAT 899. J Mol Struct 1993, 301:211–226.CrossRef 35. Gouffi K, Pichereau V, Rolland HDAC inhibitor JP, Thomas D, Bernard T,

Blanco C: Sucrose is a nonaccumulated osmoprotectant in Sinorhizobium meliloti . J Bacteriol 1998, 180:5044–5051.PubMed 36. Essendoubi M, Brhada F, Eljamali JE, Filali-Maltouf A, Bonnassie S, Georgeault S, Blanco C, Jebbar M: Osmoadaptative responses in the rhizobia nodulating Acacia isolated from south-eastern Moroccan Sahara. Environ Microbiol 2007, 9:603–611.PubMedCrossRef 37. Oren A: Bioenergetic aspects of halophilism. Microbiol Mol Biol Rev 1999, 63:334–348.PubMed 38. Strøm AR, Kaasen I: Trehalose metabolism in Escherichia coli : stress protection and stress regulation of gene expression. Mol Microbiol 1993, 8:205–210.PubMedCrossRef 39. Alarico S, Empadinhas N, Simões C, Silva Z, Henne A, Mingote A, Santos H, da Costa MS: Distribution of genes for synthesis of trehalose and mannosylglycerate in Thermus spp. and direct correlation of these genes with halotolerance. Appl Environ Microbiol 2005, 71:2460–2466.PubMedCrossRef 40. Streeter JG, Gómez ML: Three enzymes for trehalose synthesis in Bradyrhizobium cultured bacteria and in bacteroids from soybean nodules. Appl Environ Microbiol 2006, 72:4250–4255.PubMedCrossRef 41. Streeter JG, Bhagwat A: Biosynthesis of trehalose from maltooligosaccharides in Rhizobia. Can J Microbiol 1999,

45:716–721.PubMedCrossRef 42. Frey PA: The Leloir pathway: a mechanistic imperative for three enzymes to change the stereochemical configuration Adenosine of a single carbon in galactose. FASEB J 1996, 10:461–70.PubMed 43. Bock A, Curtiss III R, Kaper JB, Karp PD, Neidhardt FC, Nystrom T, Slauch JM, Squires CL, (eds): EcoSal- Escherichia coli and Salmonella : Cellular and Molecular Biology. [http://​www.​ecosal.​org] 44. Empadinhas N, Marugg JD, Borges N, Santos H, da Costa MS: Pathway for the synthesis of mannosylglycerate in the hyperthermophilic archaeon Pyrococcus horikoshii . Biochemical and genetic characterization of key enzymes. J Biol Chem 2001, 276:43580–43588.PubMedCrossRef 45. KEGG: Kyoto Encyclopedia of Genes and Genomes. [http://​www.​genome.​jp/​kegg/​kegg2.​html] 46.

During the synthesis, sulfuric acid was added to the mixture of the graphite microflakes (#043480, Alfa Aesar, Ward Hill, MA, USA) and KMnO4 as an oxidant and then it was mechanochemically treated using a planetary ball mill. The product of the mechanochemical treatment was washed on a glass filter by distilled water to remove the residues of the reagents soluble in water and

undesirable products of the oxidation reaction, then by aqueous hydrochloric acid to remove manganese oxides insoluble in water, which were formed as a result of reduction of KMnO4, and finally with water to remove the residue of the acid. The product was placed in water where it quickly swelled and formed a stable dispersion of GO which was used thereafter. The prepared GO had C:H:O equal to 1.2:0.58:1.0 and an absorption maximum in UV-vis spectrum at 230 nm. Selleck CAL-101 It consisted of mono- and few-layered particles according I-BET-762 purchase to AFM and possessed

photoluminescence with maximum of about 450 nm. We used the GNPs produced by the Nikolaev Institute of Inorganic Chemistry, Siberian Branch of RAS (Novosibirsk, Russia). In accordance with the data of X-ray analysis and Raman spectroscopy, the GNPs predominantly consisted of 10 to 15 graphene layers with partial contribution of two- to three-layered nanoparticles. The lateral size of the GNPs was in the range from 5 to 9 μm [22]. The graphene monolayer on Cu foil was purchased from Aldrich,

Niclosamide and HOPG was produced by State Scientific Research Institute of Structural Graphite Based Materials ‘NII Graphite’ (Moscow, Russian Federation). The stock aqueous solution of Thy (1 mg/ml) was first prepared and then divided into two aliquots. One part of the solution was taken for further experiments. Another part of the stock solution was ultrasonically mixed (15 min), with a definite amount of the GO to obtain Thy/GO = 100:1 weight ratio. The samples for further studies were prepared by depositing a drop of Thy or Thy/GO solution on a glass substrate for CARS and on a metallic surface for the Raman experiments. Raman measurements The Raman spectra of the monolayer graphene on Cu and HOPG were registered by inVia Raman microscope (C646 molecular weight Renishaw, Wotton-under-Edge, UK) using a laser with 633-nm wavelength and spot size of 1 μm. The Raman spectra of the MWCNTs, GO, and GNPs were also registered by inVia Raman microscope (Renishaw) using a diode laser with a wavelength of 785 nm. The SERS analysis of Thy/GO and Thy/MWCNT complexes was performed using the same laser. The band of Si at 520 cm-1 was used as the reference for wavenumber calibration. The WiRE 3.4 software (Renishaw) was used for Raman data acquisition and data analysis. Carbon materials can be effectively characterized by Raman spectroscopy.

Recent systematic reviews have concluded that there is little evidence of any significant benefit (or harm) from combined or alternating treatment compared with the use of either drug alone [80, 81] and, in their recent update, VX-680 NICE concluded that there was little evidence in the community that alternating therapy improves distress. Alternating the two agents is therefore only recommended if both have been ineffective as standalone treatments [2], the proviso

being how a parent defines ‘ineffective’. Factors such as parental anxiety, poorly obtained or recorded temperatures, subjective assessment of level of discomfort or distress, and a lack of knowledge on the time to onset of antipyretic effect may contribute both to dosing more frequently than recommended and to a PRI-724 in vivo perceived lack of response to monotherapy, resulting in unnecessary (and potentially harmful) use of alternating therapy [15]. A further consideration regarding alternating treatment is the possibility of parental confusion, which may result in accidental overdose or underdosing [15, 82, 83]. While

the recommended dosing interval for ibuprofen is 6 hours, it is 4 hours for paracetamol, therefore a simple alternating dosing regimen can be difficult. It is possible that treatment this website with a single combined dose of ibuprofen and paracetamol may offer a more effective option, with a reduced risk of dosing confusion compared with alternating therapy. There is a theoretical benefit to the co-administration of two antipyretics with different modes of action. Data in adults suggest that co-administration of ibuprofen and paracetamol provides highly effective pain relief [84] and antipyretic efficacy [85] (although distress was not measured in these patients), with a similar safety profile to each agent alone [86]. However, SPTBN5 efficacy and safety data for combination therapy in children are lacking and, therefore, currently the author’s recommendation

would be that this practice is not suggested for general OTC usage, in agreement with the latest NICE recommendations. 4 Summary and Conclusions The NICE guidelines give equal recommendation to the use of paracetamol or ibuprofen for the short-term treatment of distress in low-risk feverish children [2]. Therefore, the caregiver or HCP has to make a choice between these readily available OTC agents. The aim of this review has been to compile and compare the efficacy and safety data from available clinical studies that directly compare ibuprofen and paracetamol such that any clinically relevant differences can be considered and sensible conclusions drawn as to whether one agent has advantage over the other, and to enable the caregiver (or HCP) to make an informed choice.

(XLS 106 KB) References 1. Lindsay JA: Genomic variation and evolution of Staphylococcus aureus. Int J Med Microbiol 2010, 300:98–103.PubMedCrossRef 2. SC75741 molecular weight Malachowa N, DeLeo FR: Mobile genetic elements of Staphylococcus

aureus. Cell Mol Life Sci 2010, 67:3057–3071.PubMedCrossRef 3. Yamaguchi T, Hayashi T, Takami H, Ohnishi M, Emricasan Murata T, Nakayama K, Asakawa K, Ohara M, Komatsuzawa H, Sugai M: Complete nucleotide sequence of a Staphylococcus aureus exfoliative toxin B plasmid and identification of a novel ADP-ribosyltransferase, EDIN-C. Infect Immun 2001, 69:7760–7771.PubMedCrossRef 4. Jensen SO, Lyon BR: Genetics of antimicrobial resistance in Staphylococcus aureus. Future Microbiol 2009, 4:565–582.PubMedCrossRef 5. Kadlec K, Schwarz S: Novel ABC transporter gene, vga(C), located on a multiresistance plasmid from a porcine methicillin-resistant Staphylococcus aureus ST398 strain. Antimicrob Agents Chemother 2009, 53:3589–3591.PubMedCrossRef 6. Fessler AT, Kadlec K, Schwarz S: Novel apramycin resistance gene apmA in bovine and porcine methicillin-resistant Staphylococcus aureus ST398 isolates. Antimicrob Agents Chemother selleck chemicals llc 2011, 55:373–375.PubMedCrossRef 7. Silver S, Phung LT: Bacterial heavy metal resistance: new surprises. Annu Rev Microbiol 1996, 50:753–789.PubMedCrossRef 8. Jackson MP, Iandolo JJ: Cloning and expression of the exofoliative toxin

B gene from Staphylococcus aureus. J Bacteriol 1986, 166:574–580.PubMed 9. Novick RP: Plasmid incompatibility. Microbiol Rev 1987, 51:381–395.PubMed 10. Projan

SJ, Novick R: Comparative analysis of five related Staphylococcal plasmids. Plasmid 1988, 19:203–221.PubMedCrossRef 11. Jensen LB, Garcia-Migura L, Valenzuela AJS, Løhr , Hasman H, Aarestrup FM: A classification system for plasmids from enterococci and other Gram-positive bacteria. J Microbiol Methods 2010, 80:24–43.CrossRef 12. Corvaglia AR, François P, Hernandez D, Perron Evodiamine K, Linder P, Schrenzel J: A type III-like restriction endonuclease functions as a major barrier to horizontal gene transfer in clinical Staphylococcus aureus strains. Proc Natl Acad Sci U S A 2010, 107:11954–11958.PubMedCrossRef 13. Waldron DE, Lindsay JA: Sau1: a novel lineage-specific type I restriction-modification system that blocks horizontal gene transfer into Staphylococcus aureus and between S. aureus isolates of different lineages. J Bacteriol 2006, 188:5578–5585.PubMedCrossRef 14. Lindsay JA, Moore CE, Day NP, Peacock SJ, Witney AA, Stabler RA, Husain SE, Butcher PD, Hinds J: Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes. J Bacteriol 2006, 188:669–676.PubMedCrossRef 15. McCarthy AJ, Lindsay JA: Genetic variation in Staphylococcus aureus surface and immune evasion genes is lineage associated: implications for vaccine design and host-pathogen interactions. BMC Microbiol 2010, 10:173.PubMedCrossRef 16.